Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2025 ,inter alia, to consider and approve 1. Approval of Annual Report 2. ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences has informed the BSE that its Board of Directors will meet on August 29, 2025. The Board will consider and approve the Annual Report for the financial year ended March 31, 2025, along with the Directors' Report, Management Discussion & Analysis, and Financial Statements. It will also finalise the date, time, and venue of the company's 32nd Annual General Meeting (AGM) and approve the AGM notice. Additionally, the Board will appoint a new Statutory Auditor (M/s Neeraj Arora & Associates) and a Secretarial Auditor (Mr. Harish Kumar) each for a 5-year term, and re-appoint Managing Director Mr. Sameer Goel who retires by rotation.
This is a routine pre-AGM board meeting intimation with no major strategic or financial surprises. Shareholders can expect the audited FY25 results to be formally approved and the AGM date to be announced soon. The change of statutory auditor after a 5-year term is a standard governance step and should not materially affect the stock.